Lamotrigine (Lamictal IR) for the treatment of bipolar disorder

Expert Opinion on Pharmacotherapy

Volumn 13, Issue 17, 2012, Pages 2565-2571

  Bowden, Charles L ^a   Singh, Vivek ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bipolar; Depression; Lamotrigine; Mania; Treatment

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; FLUOXETINE PLUS OLANZAPINE; HALOPERIDOL; INOSITOL; LAMICTAL IR; LAMOTRIGINE; LITHIUM; LORAZEPAM; PAROXETINE; PLACEBO; RISPERIDONE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DEPRESSION; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; HAMILTON SCALE; HUMAN; HYPOMANIA; LITHIUM BLOOD LEVEL; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR DEPRESSION; MANIA; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAPID CYCLING BIPOLAR DISORDER; REVIEW; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; TREATMENT OUTCOME; TRIAZINES;

EID: 84869830298     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2012.741590     Document Type: Review

References (26)

1. Calabrese JR, Huffman RF, White RL, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008;10:323-33
2. Calabrese JR, Bowden CL, Sachs GS, et al. A. Double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88
3. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009;194:4-9
4. Brown EB, McElroy S, Keck PE, et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiat 2006;67:1025-33
5. van der Loos ML, Mulder PG, Hartong EG, et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiat 2009;70:223-31
6. van der Loos MLM, Mulder PG, Hartong EG, et al. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. Bipolar Disord 2011;13:111-17
7. Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiat 2006;163:210-16
8. Schaffer A, Zuker P, Levitt AJ. A Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord 2006;96:95-9
9. Nolen WA, Kupka RW, Hellemann G, et al. Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand 2007;115:360-5
10. Barbee JG, Thompson TR, Jamhour NJ, et al. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression. J Clin Psychiat 2011;72:1405-12
11. Normann C, Hummel B, Scharer LO. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double blind study. J Clin Psychiat 2002;63:337-44
12. Barbosa L, Berk M, Vorster M. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J Clin Psychiat 2003;64:403-7
13. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind placebo-controlled prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J Clin Psychiat 2000;61:841-50
14. Goldsmith DR, Wagstaff AJ, Ibbotson T, et al. Lamotrigine: a review of its use in bipolar disorder. Drugs 2003;63:2029-50
15. Calabrese JR, Bowden CL, Sachs G, et al. A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depresed Patients With Bipolar I Disorder. J Clin Psychiat 2003;64:1013-24
16. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400
17. Licht RW, Nielsen JN, Gram LF, et al. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord 2010;12:483-93
18. Bowden CL, Tohen M, Mintz J, et al. Development of Novel Integrative Multistate Measures of Efficacy, Tolerability and Functional Status in Maintenance Clinical Trials for Bipolar Disorder. Annual Meeting of the ACNP Kona; Hawaii; 2011
19. Bowden CL, Singh V, Weisler R, et al. Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression. Acta Psychiatr Scand 2012;1-9
20. Goldberg JF, Perlis RH, Bowden CL, et al. Manic symptoms during depressive episodes in 1, 380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiat 2009;166:173-81
21. Perlis RH, Ostacher MJ, Goldberg JF, et al. Transition to mania during treatment of bipolar depression. Neuropsychopharmacology 2010;35:2545-52
22. Severus WE, Lipkovich IA, Licht RW, et al. In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A posthoc analysis of the maintenance study by Tohen. Eur Psychiatry 2005;25:443-9
23. Keck PE Jr, Bowden CL, Meinhold JM, et al. Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy. Int J Psychiatry Clin Pract 2005;9:271-7
24. Ghaemi NS, Shirzadi AA, Filkowski MM. Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder. Medscape J Med 2008;10:211
25. van der Loos MLM, Calabrese JR, Nolen WA, Muzina DJ. Pharmacological profile and clinical utility of lamotrigine in mood disorders. In: Akiskal HS, Tohen M, editors. Bipolar psychopharmacotherapy. 2nd edition. Wiley Blackwell; West Sussex, UK; 2012. p. 45-60
26. Mitchell PB, Hadzi-Pavlovic D, Evoniuk G, et al. Factor analysis in bipolar depression and response to lamotrigine. submitted for publication 2012